JP2019070571A - Indication of reactivity of antigen expression and c-myc determination method of gene translocation - Google Patents

Indication of reactivity of antigen expression and c-myc determination method of gene translocation Download PDF

Info

Publication number
JP2019070571A
JP2019070571A JP2017196492A JP2017196492A JP2019070571A JP 2019070571 A JP2019070571 A JP 2019070571A JP 2017196492 A JP2017196492 A JP 2017196492A JP 2017196492 A JP2017196492 A JP 2017196492A JP 2019070571 A JP2019070571 A JP 2019070571A
Authority
JP
Japan
Prior art keywords
reactivity
positive
myc
symbol
antigen expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017196492A
Other languages
Japanese (ja)
Other versions
JP6592854B2 (en
Inventor
玲 一迫
Rei Ichisako
玲 一迫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2017196492A priority Critical patent/JP6592854B2/en
Publication of JP2019070571A publication Critical patent/JP2019070571A/en
Application granted granted Critical
Publication of JP6592854B2 publication Critical patent/JP6592854B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

To provide an indication of reactivity of antigen expression facilitating absolute negative/high probability positive detection of c-MYC gene translocation, and a c-MYC determination method of gene translocation.SOLUTION: Reactivities of antigen expression by immunohistochemistry of c-myc protein are classified into at least 3 types: positive, weak positive and negative. The area ratio of each type of reactivities in the observation area with an optical microscope is calculated. Reactivity symbols indicate each type of the reactivities. Ratio symbol indicates the area ratio of each type of the reactivities to the other types of reactivity. Display symbol displayed while associating the reactive symbol with the ratio symbol is indicated to a displayed item, and an indication of reactivity of antigen expression is created. When the respective items occupy approximately the same one third; i.e., the observation area of positive is 30% to 35%; the observation area of weak positive is 30% to 35%; and the observation area of negative is 30% to 35%, the c-MYC gene translocation is determined that the locus is negative.SELECTED DRAWING: Figure 1

Description

本発明は、免疫組織化学の結果についての抗原発現の反応性の表記物およびc−MYC遺伝子転座の判定方法に関する。   The present invention relates to indicia of reactivity of antigen expression for immunohistochemistry results and methods of determining c-MYC gene translocation.

従来、免疫組織化学の結果については抗原発現の反応性(immunoreactivity:陽性、弱陽性、陰性等)と、それらが面積的に占める大まかな割合(proportion)との2要素を病理医が個々に自分の文章で記載しており、双方を共に示すための共通した表記方法がなかった。このため、数値という絶対値で結果を示すことが多い他の医学データと異なり、データの相互比較は行われていなかった。
例えば、骨髄、血液およびリンパ節からなる群から選択される試料中の血液系悪性腫瘍由来の悪性細胞を同定するためのインビトロ法として、悪性細胞における1型5−HTRおよび/または2型5−HTRの発現細胞を免疫細胞化学によって検出する方法が開示されている(例えば、特許文献1参照)。
Conventionally, pathologists individually have two elements, ie, immunoreactivity (positive, weak positive, negative, etc.) for the result of immunohistochemistry, and a rough proportion (proportion) occupied by them. There is no common notation for showing both together. For this reason, unlike other medical data which often show the result as an absolute value, numerical data was not compared with each other.
For example, as an in vitro method for identifying malignant cells from hematologic malignancies in a sample selected from the group consisting of bone marrow, blood and lymph nodes, type 1 5-HTR and / or type 2 5- A method of detecting HTR-expressing cells by immunocytochemistry is disclosed (see, for example, Patent Document 1).

特表2017−526629号公報Japanese Patent Application Publication No. 2017-526629

特許文献1の方法においても、免疫組織化学の結果の表記方法は示されておらず、病理医が個々に抗原発現の反応性を陽性と陰性の2種類に分け、その面積比率を感覚的にとらえて悪性細胞を言語で同定することから、同定の精度や再現性、イメージ想定が悪いという課題があった。   Also in the method of Patent Document 1, the method of describing the result of immunohistochemistry is not shown, and a pathologist individually divides the reactivity of the antigen expression into two types, positive and negative, and sensitarily the area ratio Since capturing and identifying malignant cells in a language, there is a problem that the accuracy and reproducibility of identification and the image assumption are bad.

本発明は、このような従来の課題に着目してなされたもので、c−MYC遺伝子の転座の陰性・高確率な陽性の判定を容易にする抗原発現の反応性の表記物およびc−MYC遺伝子転座の判定方法を提供することを目的とする。   The present invention was made in view of such conventional problems, and it is an expression of reactivity of antigen expression that facilitates negative / high probability positive determination of translocation of c-MYC gene and c- An object of the present invention is to provide a method of determining MYC gene translocation.

上記目的を達成するために、本発明に係る抗原発現の反応性の表記物は、免疫組織化学による抗原発現の所定の反応性を示す反応性記号と、前記所定の反応性の他の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を有することを、特徴とする。   In order to achieve the above object, the expression of reactivity of antigen expression according to the present invention comprises a reactivity symbol indicating a predetermined reactivity of antigen expression by immunohistochemistry and other reactivity of the predetermined reactivity. It is characterized by having a display symbol displayed in association with a ratio symbol indicating an area ratio to.

本発明に係る抗原発現の反応性の表記物は、c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類したとき各種類の反応性を示す反応性記号と、各種類の反応性の他の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を有することが好ましい。   The expression of the reactivity of the expression of the antigen according to the present invention, when the reactivity of the expression of the antigen by immunohistochemistry of the c-myc protein is classified into at least three types of positive, weak positive and negative. It is preferable to have a display symbol which is displayed in association with a symbol of reactivity and a ratio symbol indicating an area ratio of each type of reactivity to other reactivity.

抗原発現の反応性の分類は、3種類のほか、4種類または5種類以上であってもよい。4種類の場合、抗原発現の所定の反応性を示す反応性記号としては、例えば、陽性を「+」、弱陽性を「(weak)+」、非常に弱い陽性を「(very weak)+」、陰性を「−」で示す記号が挙げられる。なお、「陽性」は、通常強度の陽性を意味する。   The classification of reactivity of antigen expression may be four or five or more in addition to three. In the case of four types, for example, “+” for positive, “(weak) +” for weak positivity, and “(very weak) +” for very weak positivity as reactivity symbols indicating predetermined reactivity of antigen expression. And negative signs with "-". "Positive" usually means strong positive.

面積比率を示す比率記号としては、例えば、左側に反応性記号で示される反応性が60%〜70%のとき「>」、左側に反応性記号で示される反応性が75%〜90%のとき「>>」、左側に反応性記号で示される反応性が99%以上のとき「>>>」で示す記号が挙げられる。   The ratio symbol indicating the area ratio is, for example, “>” when the reactivity represented by the reactivity symbol on the left is 60% to 70%, and the reactivity represented by the reactivity symbol on the left is 75% to 90% When ">>" and the reactivity shown by the reactivity symbol is 99% or more on the left side, the symbol shown by ">>>" is mentioned.

本発明において、表記物は、記号を表示可能ないかなるものであってもよく、例えば、印刷物その他の紙面、黒板、モニター画像、スライド投射画像などが挙げられる。
本発明に係る抗原発現の反応性の表記物を用いることにより、c−MYC遺伝子の転座の陰性・陽性の判定を容易にすることができる。
In the present invention, the indication may be anything that can display a symbol, and examples include printed matter and other paper, blackboard, monitor image, slide projection image, and the like.
The negative / positive determination of the translocation of c-MYC gene can be facilitated by using the display of the reactivity of the antigen expression according to the present invention.

本発明に係るc−MYC遺伝子転座の判定方法は、c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類し、観察領域に占める各種類の反応性の面積比率を求め、各種類の反応性を示す反応性記号と、各種類の反応性の他の種類の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を被表記物に表示して前述の抗原発現の反応性の表記物を作成し、前記陽性が前記観察領域の30〜35%、前記弱陽性が前記観察領域の30〜35%、前記陰性が前記観察領域の30〜35%を占めるとき、c−MYC遺伝子の転座が陰性であると判定することを特徴とする。   The method of determining c-MYC gene translocation according to the present invention classifies the reactivity of antigen expression by immunohistochemistry of c-myc protein into at least three types of positive, weak positive and negative, and occupies each of the observation areas. A display symbol in which area ratios of types of reactivity are determined, and a reactivity symbol indicating each type of reactivity is associated with a ratio symbol indicating an area ratio of each type of reactivity to other types of reactivity The above-mentioned display of reactivity of antigen expression is made by displaying on the subject, the positive is 30 to 35% of the observation area, the weak positive is 30 to 35% of the observation area, the negative is It is characterized in that when it occupies 30 to 35% of the observation area, it is determined that the translocation of the c-MYC gene is negative.

本発明に係る他のc−MYC遺伝子転座の判定方法は、c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類し、観察領域に占める各種類の反応性の面積比率を求め、各種類の反応性を示す反応性記号と、各種類の反応性の他の種類の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を被表記物に表示して前述の抗原発現の反応性の表記物を作成し、前記陽性が前記観察領域の75〜90%であるとき、c−MYC遺伝子の転座が陽性になり得る確率が高いと判定することを特徴とする。   Another determination method of c-MYC gene translocation according to the present invention classifies the reactivity of antigen expression by immunohistochemistry of c-myc protein into at least three types of positive, weak positive and negative, The area ratio of each type of reactivity is determined, and the reactivity symbol indicating each type of reactivity is displayed in association with the ratio symbol indicating the area ratio of each type of reactivity to the other type of reactivity. The indicator is displayed on the subject to make the aforementioned indicator of the reactivity of the antigen expression, and when the positive is 75 to 90% of the observation area, the translocation of the c-MYC gene becomes positive. It is characterized in that it is determined that the probability of obtaining is high.

本発明に係るc−MYC遺伝子転座の判定方法は、本発明者がc−myc蛋白の免疫組織化学による抗原発現の反応性を陽性と弱陽性と陰性との3種類に分類して臨床データを分析することにより、経験的に得られた判定方法である。
本発明に係るc−MYC遺伝子転座の判定方法により、所定の条件を満たす場合には、精密な検査を行わずに、高い精度でc−MYC遺伝子の転座の陰性・陽性の判定が可能となる。
なお、本発明において、「観察領域」は、撮影された顕微鏡写真全体でも、範囲を特定した一部の領域であってもよい。
In the method of determining c-MYC gene translocation according to the present invention, the present inventors classify the reactivity of the antigen expression by immunohistochemistry of c-myc protein into three types of positive, weak positive and negative, and clinical data It is a judgment method obtained empirically by analyzing
According to the method of determining c-MYC gene translocation according to the present invention, when a predetermined condition is satisfied, negative / positive determination of translocation of c-MYC gene can be performed with high accuracy without performing a precise test. It becomes.
In the present invention, the “observation region” may be the entire photographed micrograph or a partial region specifying a range.

本発明によれば、c−MYC遺伝子の転座の陰性・高確率な陽性の判定を容易にする抗原発現の反応性の表記物およびc−MYC遺伝子転座の判定方法を提供することができる。   According to the present invention, it is possible to provide a representation of the reactivity of antigen expression and a method for determining c-MYC gene translocation that facilitates negative and high probability positive determination of translocation of c-MYC gene. .

本発明の実施の形態の抗原発現の反応性の表記物の表記方法を示すフローチャートである。It is a flowchart which shows the notation method of the representation of the reactivity of the antigen expression of embodiment of this invention. 病変部生検を免疫組織化学的に染色した4つの顕微鏡写真である。4 is four photomicrographs of immunohistochemically stained lesion biopsies.

以下、図面に基づき、本発明の実施の形態について説明する。
図1は、本発明の実施の形態の抗原発現の反応性の表記物の表記方法を示すフローチャートである。図2は、病変部生検を免疫組織化学的に染色した4つの顕微鏡写真である。
Hereinafter, an embodiment of the present invention will be described based on the drawings.
FIG. 1 is a flow chart showing a method of displaying a representation of reactivity of antigen expression according to the embodiment of this invention. FIG. 2 shows four photomicrographs of immunohistochemically stained lesion biopsies.

悪性腫瘍由来の悪性細胞や正常ないし病的細胞における各種蛋白質を同定するため、病変部生検を免疫組織化学的に染色した顕微鏡写真から抗原発現の反応性が陽性か陰性かを判定することが行われている。病変部生検の顕微鏡写真の準備と、抗原発現の反応性の評価は以下の方法で行う。   In order to identify various proteins in malignant cells derived from malignant tumors and normal or pathological cells, it is necessary to determine whether the reactivity of antigen expression is positive or negative from photomicrographs of immunohistochemically stained lesion biopsies. It has been done. Preparation of photomicrographs of lesion biopsies and evaluation of reactivity of antigen expression are performed as follows.

まず、病変部位を採取し、ホルマリン固定後に型の如く、パラフィン切片を作製する。次に、抗c−myc抗体を一次抗体として用い、パラフィン切片を免疫組織化学的に染色する。染色標本を顕微鏡で観察して、c−myc蛋白の免疫組織化学による抗原発現の反応性を表示記号により表記し、接眼10倍・対物40倍レンズの光学顕微鏡で観察する。   First, the lesion site is collected, and after formalin fixation, paraffin sections are prepared as a mold. Next, paraffin sections are immunohistochemically stained using an anti-c-myc antibody as a primary antibody. The stained sample is observed with a microscope, and the reactivity of the antigen expression by immunohistochemistry of c-myc protein is indicated by a display symbol, and observed with an optical microscope of an eyepiece 10 × objective 40 × lens.

抗原発現の反応性の表示記号から反応性の評価を行い、c−MYC遺伝子の転座の、悪性細胞におけるc−myc蛋白の発現の程度を陽性、弱陽性、非常に弱い陽性(弱陽性と陰性の間の強度)、陰性の4種類に分けて観察し、それぞれの抗原発現の面積的な割合を、図1に示すフローチャートに従って記号表記する。記号表記を行う被表記物は、所定の用紙のほか、パーソナルコンピュータのモニター画像であってもよい。   The reactivity is evaluated from the display symbol of the reactivity of antigen expression, and the degree of expression of c-myc protein in malignant cells is positive, weak positive, very weak positive (weak positive) as the translocation of c-MYC gene The intensity between negatives) and negatives are observed separately, and the area ratio of each antigen expression is symbolized according to the flow chart shown in FIG. An object to be marked may be a monitor image of a personal computer in addition to a predetermined sheet.

図1に示すように、抗原発現の反応性の表記物を表記するとき、観察領域に占める面積で「優に5割を超える反応性パターンがあるか?」で2つに分け、yesの場合、「反応性パターンは1種類か2種類か3種類か?」で3つに分け、1種類のとき、「+」、「(weak)+」、「(very weak)+」、「−」のいずれかの反応性記号を表示記号とする。   As shown in FIG. 1, when expressing a representation of the reactivity of antigen expression, the area occupied in the observation area is divided into two by “Are well over 50% of the reactivity pattern?”, And the case of yes , "One or two types or three types of reactivity patterns", divided into three, and one type, "+", "(weak) +", "(very weak) +", "-" Mark one of the reactivity symbols as the display symbol.

「+」、「(weak)+」、「(very weak)+」、「−」の反応性記号は、c−myc蛋白の免疫組織化学による抗原発現の反応性を4種類に分類したときの各種類の反応性を示している。免疫組織化学による抗原発現の所定の反応性のうち、「+」は陽性を、「(weak)+」は弱陽性を、「(very weak)+」は非常に弱い陽性を、「−」は陰性を示している。病変部生検を免疫組織化学的に染色したカラーの顕微鏡写真では、陽性は茶色に、弱陽性は薄い茶色に、非常に弱い陽性はかなり薄い茶色(ベージュ系)に、陰性は完全な白色に写っている。   The reactivity symbols “+”, “(weak) +”, “(very weak) +” and “−” indicate that the reactivity of the antigen expression by immunohistochemistry of c-myc protein is classified into four types. Each type of reactivity is shown. Of the predetermined reactivity of antigen expression by immunohistochemistry, “+” is positive, “(weak) +” is weak, “(very weak) +” is very weak, “-” is It shows negative. In the photomicrograph of the immunohistochemically stained color of the lesion biopsy, positive is brown, weak positive is light brown, very weak positive is fairly light brown (beige), negative is completely white It is reflected.

反応性パターンが2種類のときには、「+」、「(weak)+」、「(very weak)+」、「−」のうちの2種類の反応性記号の間に「>」、「>>」、「>>>」、「>>> *」の比率記号を表示する。図1に示すように2種類の反応性記号の反応性の面積比率に応じて、左側により強い反応性の反応性記号を表示し、右側により弱い反応性の反応性記号を表示して、比率記号を2種類の反応性記号と関連付けた表示記号とする。   When there are two types of reactivity patterns, “>” and “>>” are between two types of reactivity symbols among “+”, “(weak) +”, “(very weak) +”, and “−”. "," ">>>", ">>> *" display the ratio symbol. As shown in FIG. 1, depending on the area ratio of the reactivity of the two types of reactivity symbols, the left reactivity reactivity symbol is displayed on the left side and the lower reactivity reactivity symbol is displayed on the right side, the ratio Let the symbol be a symbol that is associated with two reactive symbols.

反応性パターンが3種類のときには、「+」、「(weak)+」、「(very weak)+」、「−」のうちの3種類の反応性記号の各反応性記号の間に「>」、「>>」の比率記号を表示する。図1に示すように3種類の反応性記号の反応性の面積比率に応じて、左側により強い反応性の反応性記号を表示し、右側により弱い反応性の反応性記号を表示して、比率記号を3種類の反応性記号と関連付けた表示記号とする。   When there are three types of reactivity patterns, “>”, “(weak) +”, “(very weak) +”, “−” among the reactivity symbols of the three reactivity symbols “>” "," Display the ratio symbol of ">>". As shown in FIG. 1, depending on the area ratio of reactivity of the three types of reactivity symbols, the left reactivity reactivity symbol is displayed on the left side, and the lower reactivity reactivity symbol is displayed on the right side, the ratio Let the symbol be a symbol that is associated with the three reactive symbols.

「優に5割を超える反応性パターンがあるか?」でnoの場合、「ほぼ5割の反応性パターンがあるか?」で2つに分け、yesのとき、「+」、「(weak)+」、「(very weak)+」、「−」のうちの2種類または3種類の反応性記号の間に「/」、「>」、「>>」、「>>>」の比率記号を表示して、比率記号を2種類または3種類の反応性記号と関連付けた表示記号とする。「/」の比率記号は、左側のより強い反応性記号の反応性と、右側のより弱い反応性の反応性記号の反応性との面積比率が47〜53%であることを示している。   In the case of no, if "no about 50% of the reactivity pattern is well over 50%", it is divided into two according to "is about 50% of the reactivity pattern", and if yes, "+", "(weak The ratio of "/", ">", ">>", ">>>" between two or three types of reactivity symbols among +), "(very weak) +" and "-" Display the symbol, and make the ratio symbol a display symbol associated with two or three types of reactive symbols. The ratio symbol "/" indicates that the area ratio of the reactivity of the stronger reactivity symbol on the left to the reactivity of the reactivity symbol of the weaker reactivity on the right is 47-53%.

「ほぼ5割の反応性パターンがあるか?」でnoのとき、「+」、「(weak)+」、「(very weak)+」、「−」のうちの3種類の反応性記号の間に「/」、「>>」、「>>>」の比率記号を表示して、比率記号を3種類の反応性記号と関連付けた表示記号とする。3種類の反応性記号の間に表示される「/」の比率記号は、各反応性記号の反応性の面積比率が30〜35%であることを示している。   When "no", "is there about 50% of the reactivity pattern", "+", "(weak) +", "(very weak) +", and "-" The ratio symbols of “/”, “>>”, “>>>” are displayed in between, and the ratio symbols are displayed symbols associated with the three types of reactivity symbols. The ratio symbol “/” displayed between the three types of reactivity symbols indicates that the area ratio of reactivity of each reactivity symbol is 30 to 35%.

図2に示す顕微鏡写真について、各写真の抗原発現の反応性を表示記号で示すと、Aは「+>>(weak)+」で、Bは「+/(weak)+>>−」で、Cは「+/(weak)+/−」で、Dは「−」で示される。   In the photomicrographs shown in FIG. 2, when the reactivity of antigen expression in each photograph is indicated by a symbol, A is “+ >> (weak) +” and B is “+ / (weak) + >> −” , C is "+ / (weak) +/-", and D is shown by "-".

病変部位を採取し、ホルマリン固定後にパラフィン切片を作製し、抗c−myc抗体を一次抗体として用いて、パラフィン切片を免疫組織化学的に染色した。染色標本を顕微鏡で観察し、図1に示すフローチャートに従って、c−myc蛋白の免疫組織化学による抗原発現の反応性を表示記号で示した。また、FISH(Fluorescence in situ hybridization)用プローブセットを用いて、c−MYC遺伝子の転座の陽性(分断ないし他遺伝子との融合を含む)と陰性(分断ないし他遺伝子との融合を含まない)を検出した。   Lesion sites were collected, paraffin sections were prepared after formalin fixation, and paraffin sections were immunohistochemically stained using anti-c-myc antibody as a primary antibody. The stained sample was observed with a microscope, and the reactivity of the antigen expression by immunohistochemistry of c-myc protein was indicated by a display symbol according to the flowchart shown in FIG. In addition, using the probe set for FISH (Fluorescence in situ hybridization), positive (including split or fusion with other genes) and negative (without split or fusion with other genes) translocation of c-MYC gene Detected.

その結果は、以下のとおりである。左側にフローチャートに従って表記した表示記号を示す。それぞれの表記の右側にFISH用プローブセットを用いて検出した、検索対象とした症例数におけるc−MYC遺伝子転座陽性の症例数を示す。また、A群、B群、C群の右側には同様の症例数とともに括弧内に割合を示す。   The results are as follows. On the left side, display symbols are shown according to the flowchart. The number of c-MYC gene translocation positive cases in the number of searched cases detected using the probe set for FISH is shown on the right side of each description. Also, on the right side of groups A, B and C, the percentages are shown in parentheses together with the number of similar cases.

A群:0/43(0%)
c−myc+/(weak)+/− ・・・ 0/43
B群:13/25(52%)
c−myc+/(weak)+>>− ・・・ 3/4
c−myc+/(weak)+>>>− ・・・ 1/2
c−myc+>(weak)+>− ・・・ 0/1
c−myc+>(weak)+>>− ・・・ 3/9
c−myc+>>(weak)+>− ・・・ 6/9
C群:8/9(89%)
c−myc+>>(weak)+ ・・・ 7/7
c−myc+>>>(weak)+ ・・・ 1/2
Group A: 0/43 (0%)
c-myc + / (weak) +/- · · · 0/43
Group B: 13/25 (52%)
c-myc + / (weak) + >>-... 3/4
c-myc + / (weak) + >>>-... 1/2
c-myc +> (weak) +>-... 0/1
c-myc +> (weak) + >>-... 3/9
c-myc + >> (weak) +>-... 6/9
Group C: 8/9 (89%)
c-myc + >> (weak) + ... 7/7
c-myc + >>> (weak) + ... 1/2

このように、免疫組織化学の結果が「c−myc+/(weak)+/−」の表示記号で示される場合、陽性が観察領域の30〜35%、弱陽性が観察領域の30〜35%、陰性が観察領域の30〜35%と、それぞれほぼ同じ3分の1程度を占めている。この場合、43件の症例中、c−MYC遺伝子の転座が陽性のものは0件、陰性のものが43件すべてであった。このことから、免疫組織化学の結果が「c−myc+/(weak)+/−」の場合、c−MYC遺伝子の転座が陰性であると判定することができる。   Thus, when the result of immunohistochemistry is indicated by the symbol "c-myc + / (weak) +/-", positive is 30 to 35% of the observation area and weak positive is 30 to 35% of the observation area Negative, 30 to 35% of the observation area, respectively, occupy approximately the same third. In this case, among 43 cases, 0 cases were positive for translocation of c-MYC gene, and all 43 cases were negative. From this, when the result of immunohistochemistry is "c-myc + / (weak) +/-", it can be determined that the translocation of the c-MYC gene is negative.

また、免疫組織化学の結果が「c−myc+>>(weak)+」の表示記号で示される場合、陽性が前記観察領域の75〜90%を占めている。この場合、7件の症例中、c−MYC遺伝子の転座が陽性のものは7件すべて、陰性のものが0件であった。このことから、免疫組織化学の結果が「c−myc+>>(weak)+」の場合、症例数が少ないもののc−MYC遺伝子の転座が高い確率で陽性になり得るものと判定することができる。   Moreover, when the result of immunohistochemistry is shown by the display symbol "c-myc + >> (weak) +", positive occupies 75 to 90% of the observation area. In this case, among the seven cases, all seven cases were positive for translocation of the c-MYC gene and none were negative. From this, when the result of immunohistochemistry is “c-myc + >> (weak) +”, it can be determined that the translocation of c-MYC gene can be positive with a high probability although the number of cases is small. it can.

「c−myc+>>(weak)+」の表示記号で示される場合、すなわち、陽性が観察領域の75〜90%を占める場合、遺伝子Aに異常が生じている確率は9割以上になる。蛋白質レベルの発現様式を上述の表示記号で示すことによって、遺伝子異常の検出が容易になる。遺伝子Aの異常があると、患者の予後は不良になることが既に知られているので、免疫組織化学による蛋白質発現様式で患者の予後まで推定することができる。   When indicated by the symbol "c-myc + >> (weak) +", that is, when the positive occupies 75 to 90% of the observation area, the probability that the gene A is abnormal is 90% or more. By showing the expression mode at the protein level with the above-mentioned symbols, detection of genetic abnormalities is facilitated. Since it is already known that a patient's prognosis will be poor if there is an abnormality in gene A, it is possible to estimate the patient's prognosis in a protein expression mode by immunohistochemistry.

このように、免疫組織化学の結果が「c−myc+/(weak)+/−」の表示記号で示される場合、精密な検査を行わずにc−MYC遺伝子の転座の陰性判定が可能となる。また、「c−myc+>>(weak)+」の表示記号で示される場合には、抗原発現の反応性の表記物を用いることにより、c−MYC遺伝子の転座の陽性判定をかなり高い確率で行うことを容易にすることができる。   Thus, when the result of immunohistochemistry is indicated by the symbol "c-myc + / (weak) +/-", it can be judged negative for translocation of c-MYC gene without detailed examination. Become. In addition, when indicated by the symbol “c-myc + >> (weak) +”, the probability of positive determination of translocation of c-MYC gene is considerably high by using a representation of reactivity of antigen expression Can be done easily.

前述の表示記号によって、これまで個々の病理医がまちまちの長さで文章表記してきた免疫組織化学の所見が一定の法則に従ってかなり短く記号化され、それによって見易くかつ相互の比較が容易になる。記載時間の短縮にもなる。また、従来、抗原発現の反応性を陽性と陰性の2段階でとらえていたものが少なくとも陽性と弱陽性と陰性の3段階等でとらえることとなり、c−MYC遺伝子の転座の陰性・陽性の判定の精度を向上させることができる。
さらに、免疫組織化学の所見をビッグデータとして取り扱って、大規模症例数の解析や分析が可能となる。
The above symbols make the immunohistochemistry findings, which so far have been written by different pathologists at different lengths, so as to be considerably shorter according to a certain rule, which makes them easier to read and to compare with each other. It will also shorten the description time. In addition, conventionally, the reaction of antigen expression in two steps of positive and negative is at least in three steps of positive and weak positive and negative etc. c-MYC gene translocation negative / positive The accuracy of the determination can be improved.
Furthermore, handling the findings of immunohistochemistry as big data enables analysis and analysis of large-scale cases.

Claims (4)

免疫組織化学による抗原発現の所定の反応性を示す反応性記号と、前記所定の反応性の他の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を有することを、特徴とする抗原発現の反応性の表記物。   It is characterized by having a display symbol in which a reactivity symbol indicating a predetermined reactivity of antigen expression by immunohistochemistry and a ratio symbol indicating an area ratio to the other reactivity of the predetermined reactivity are associated with each other. Indication of the reactivity of antigen expression. c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類したとき各種類の反応性を示す反応性記号と、各種類の反応性の他の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を有することを、特徴とする抗原発現の反応性の表記物。   When the reactivity of the antigen expression by immunohistochemistry of c-myc protein is classified into at least positive, weak positive and negative at least three types, the reactivity symbol showing each type of reactivity and the other types of reactivity A symbol of reactivity of antigen expression characterized by having a display symbol displayed in association with a ratio symbol indicating an area ratio to reactivity. c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類し、観察領域に占める各種類の反応性の面積比率を求め、各種類の反応性を示す反応性記号と、各種類の反応性の他の種類の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を被表記物に表示して請求項2記載の抗原発現の反応性の表記物を作成し、前記陽性が前記観察領域の30〜35%、前記弱陽性が前記観察領域の30〜35%、前記陰性が前記観察領域の30〜35%を占めるとき、c−MYC遺伝子の転座が陰性であると判定することを特徴とするc−MYC遺伝子転座の判定方法。   The reactivity of the antigen expression by immunohistochemistry of c-myc protein is classified into at least three types of positive, weak positive and negative, the area ratio of each type of reactivity occupying the observation area is determined, and each type of reactivity The antigen expression according to claim 2, wherein a display symbol displayed in association with a symbol indicating the reactivity and a ratio symbol indicating the area ratio of each type of reactivity to the reactivity of the other type is displayed on the subject When the positive represents 30 to 35% of the observation area, the weak positive 30 to 35% of the observation area, and the negative 30 to 35% of the observation area; A method for determining c-MYC gene translocation, which comprises determining that the translocation of c-MYC gene is negative. c−myc蛋白の免疫組織化学による抗原発現の反応性を少なくとも陽性と弱陽性と陰性との3種類に分類し、観察領域に占める各種類の反応性の面積比率を求め、各種類の反応性を示す反応性記号と、各種類の反応性の他の種類の反応性に対する面積比率を示す比率記号とが関連付けて表示された表示記号を被表記物に表示して請求項2記載の抗原発現の反応性の表記物を作成し、前記陽性が前記観察領域の75〜90%であるとき、c−MYC遺伝子の転座が陽性になり得る確率が高いと判定することを特徴とするc−MYC遺伝子転座の判定方法。

The reactivity of the antigen expression by immunohistochemistry of c-myc protein is classified into at least three types of positive, weak positive and negative, the area ratio of each type of reactivity occupying the observation area is determined, and each type of reactivity The antigen expression according to claim 2, wherein a display symbol displayed in association with a symbol indicating the reactivity and a ratio symbol indicating the area ratio of each type of reactivity to the reactivity of the other type is displayed on the subject And producing a sign of reactivity, and determining that the probability that the translocation of the c-MYC gene can be positive is high when the positivity is 75 to 90% of the observation area. Determination method of MYC gene translocation.

JP2017196492A 2017-10-10 2017-10-10 Method for determining c-MYC gene translocation Active JP6592854B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017196492A JP6592854B2 (en) 2017-10-10 2017-10-10 Method for determining c-MYC gene translocation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017196492A JP6592854B2 (en) 2017-10-10 2017-10-10 Method for determining c-MYC gene translocation

Publications (2)

Publication Number Publication Date
JP2019070571A true JP2019070571A (en) 2019-05-09
JP6592854B2 JP6592854B2 (en) 2019-10-23

Family

ID=66440595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017196492A Active JP6592854B2 (en) 2017-10-10 2017-10-10 Method for determining c-MYC gene translocation

Country Status (1)

Country Link
JP (1) JP6592854B2 (en)

Also Published As

Publication number Publication date
JP6592854B2 (en) 2019-10-23

Similar Documents

Publication Publication Date Title
US10025271B2 (en) Method and system for detecting and/or classifying cancerous cells in a cell sample
JP6654634B2 (en) Methods, systems and devices for quantitatively analyzing heterogeneous biomarker distributions
JP7092503B2 (en) Systems and methods for co-expression analysis
JP5663873B2 (en) Breast cancer pathological image diagnosis support system, breast cancer pathological image diagnosis support method, breast cancer pathological image diagnosis support program, and recording medium recording breast cancer pathological image diagnosis support program
JP5184087B2 (en) Methods and computer program products for analyzing and optimizing marker candidates for cancer prognosis
CN105027165B (en) Tissue object-based machine learning system for automated scoring of digital whole slides
JP6604960B2 (en) Medical image analysis to identify biomarker positive tumor cells
US8417015B2 (en) Methods and system for validating sample images for quantitative immunoassays
US9697582B2 (en) Methods for obtaining and analyzing images
CN106462767B (en) Inspection device for processing and analyzing images
JP2000513465A (en) Automatic microscope-assisted inspection method for living tissue samples and body fluid samples
JP5469070B2 (en) Method and system using multiple wavelengths for processing biological specimens
WO2012041333A1 (en) Automated imaging, detection and grading of objects in cytological samples
EP2327040B1 (en) A method and a system for determining a target in a biological sample by image analysis
Puri et al. Automated computational detection, quantitation, and mapping of mitosis in whole-slide images for clinically actionable surgical pathology decision support
CN111751371B (en) Immunohistochemical digital slide reading system and method
JP2019070571A (en) Indication of reactivity of antigen expression and c-myc determination method of gene translocation
EP3757872A1 (en) Scanning/pre-scanning quality control of slides
US11908130B2 (en) Apparatuses and methods for digital pathology
US20240170165A1 (en) Systems and methods for the detection and classification of biological structures
Lamothe et al. Erroneous Patient Tissue Contaminants in 1574 Surgical Pathology Slides: Impact on Diagnostic Error and a Novel Framework for Floater Management
Shete et al. Evaluation of Immunohistochemistry (IHC) Marker Her2 in Breast Cancer
Dubey et al. Pathology for gastrointestinal and hepatobiliary cancers using artificial intelligence
JP2011072267A (en) Method and apparatus for identifying tumor cell

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20171011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190401

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190905

R150 Certificate of patent or registration of utility model

Ref document number: 6592854

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250